Member Exclusive

First patient dosed in Japanese iPSC Parkinson’s trial

A patient in his 50s received iPSC-derived nerve cells to supplement dopamine-emitting neurons.

Go to the profile of Freya Leask
Nov 12, 2018
1
0

Please sign in or register for FREE

No comments yet.